Xylen (Ксилен) nasal drops

Xylen (Ксилен) is a widely recognized brand of nasal drops used for relieving nasal congestion. It contains xylometazoline as its active ingredient, a vasoconstrictor commonly used in over-the-counter allergy and cold medications. The product shown is manufactured by Veropharm, one of Russia's largest pharmaceutical companies.

Historically, the brand and its manufacturer have undergone significant changes in ownership. Veropharm was established in Russia and became a major player in the local pharmaceutical market. In 2014, the American healthcare giant Abbott Laboratories acquired Veropharm, strengthening its presence in the emerging Russian market. This acquisition integrated Veropharm into Abbott’s established global healthcare portfolio.

Today, while the brand remains deeply rooted in the Russian market and production facilities are primarily located within the Russian Federation, the brand is under the ultimate ownership of Abbott Laboratories, headquartered in the United States. This structure combines local production and heritage with the resources and oversight of a global pharmaceutical leader.